Switch to:
GlaxoSmithKline PLC  (NYSE:GSK) EV-to-EBITDA: 16.20 (As of Today)

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, GlaxoSmithKline PLC's enterprise value is $123,598 Mil. GlaxoSmithKline PLC's EBITDA for the trailing twelve months (TTM) ended in Jun. 2017 was $7,630 Mil. Therefore, GlaxoSmithKline PLC's EV-to-EBITDA for today is 16.20.

NYSE:GSK' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.6   Max: 35.2
Current: 15.38

5.6
35.2

During the past 13 years, the highest EV-to-EBITDA of GlaxoSmithKline PLC was 35.20. The lowest was 5.60. And the median was 9.20.

NYSE:GSK's EV-to-EBITDA is ranked higher than
55% of the 596 Companies
in the Global industry.

( Industry Median: 16.61 vs. NYSE:GSK: 15.38 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today, GlaxoSmithKline PLC's stock price is $40.86. GlaxoSmithKline PLC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2017 was $0.99. Therefore, GlaxoSmithKline PLC's PE Ratio for today is 41.08.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

GlaxoSmithKline PLC Annual Data

Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.15 9.97 17.26 6.32 21.37

GlaxoSmithKline PLC Quarterly Data

Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.74 30.44 21.37 19.14 16.42

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Calculation

GlaxoSmithKline PLC's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=123598.192/7629.9715821
=16.20

GlaxoSmithKline PLC's current Enterprise Value is $123,598 Mil.
GlaxoSmithKline PLC's EBITDA for the trailing twelve months (TTM) ended in Jun. 2017 was 2160.31537451 (Sep. 2016 ) + 1504.36953808 (Dec. 2016 ) + 2555.55555556 (Mar. 2017 ) + 1409.73111396 (Jun. 2017 ) = $7,630 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

GlaxoSmithKline PLC's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=40.86/0.994653256132
=41.08

GlaxoSmithKline PLC's share price for today is $40.86.
GlaxoSmithKline PLC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2017 was 0.433639947438 (Sep. 2016 ) + 0.129837702871 (Dec. 2016 ) + 0.525925925926 (Mar. 2017 ) + -0.0947503201024 (Jun. 2017 ) = $0.99.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms


Headlines

From the Internet

GSK
Sanofi Upward Trajectory 2017

- Seekingalpha 2017-10-16 11:21:51

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK